The Kors injection, which contains difelikefalin (brand name Korsuva), is used to treat moderate-to-severe itching (pruritus) associated with chronic kidney disease in adults undergoing hemodialysis.
Korsuva (Difelikefalin) Explained
Korsuva, the brand name for difelikefalin, is a kappa opioid receptor agonist. This means it works by targeting kappa opioid receptors in the body to alleviate itching.
Key Use Case: CKD-Associated Pruritus
- Chronic Kidney Disease (CKD): Korsuva is specifically designed for individuals with chronic kidney disease.
- Hemodialysis (HD): It's indicated for adults undergoing hemodialysis, a treatment that filters the blood when the kidneys can't.
- Pruritus (Itching): The primary target of Korsuva is moderate-to-severe itching caused by CKD.
In summary, Korsuva injections aim to reduce the burden of itching experienced by hemodialysis patients with chronic kidney disease.
